Conclusion
The novel nomogram developed in the current study for predicting
survival of pediatric patients with histologically confirmed brainstem
gliomas is the first to incorporate risk stratification. Therefore,
combining nomogram and risk stratification system is a convenient tool
to help clinicians identify high-risk patients and to perform targeted
adjuvant treatment.